Drug Resistance
Daptomycin useful for treating drug-resistant Gram-positive pathogens
Published in Medical Letter on the CDC and FDA, May 16th, 2004
According to recent research from the United States, "Daptomycin is a novel cyclic lipopeptide antibiotic that provides rapid bactericidal activity against Gram-positive pathogens in vitro, including methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus, vancomycin-resistant S. aureus, penicillin-resistant Streptococcus pneumoniae, and ampicillin-and vancomycin-resistant enterococci.
"The United States Food and Drug Administration recently approved daptomycin for treatment of complicated skin and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cancer Therapy
Orlistat is inhibitor of fatty acid synthase with antitumor activity - Parasitology
Common intestinal parasites reviewed - Vaccine Safety
Vaccine Adverse Event Reporting System database reviewed - Wuchereria
Wuchereria bancrofti infection more prevalent in Haiti lowlands - AIDS/HIV Therapy
Crack cocaine use reduces antiviral therapy use in women with HIV - AIDS/HIV Vaccine
Vaccine allows for infection control in macaques exposed to SHIV - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
